BE904986A - Sels de furosemide. - Google Patents

Sels de furosemide.

Info

Publication number
BE904986A
BE904986A BE6/48235A BE6048235A BE904986A BE 904986 A BE904986 A BE 904986A BE 6/48235 A BE6/48235 A BE 6/48235A BE 6048235 A BE6048235 A BE 6048235A BE 904986 A BE904986 A BE 904986A
Authority
BE
Belgium
Prior art keywords
dosage forms
furosemide
oral dosage
salts
burden
Prior art date
Application number
BE6/48235A
Other languages
English (en)
French (fr)
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of BE904986A publication Critical patent/BE904986A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
BE6/48235A 1985-07-02 1986-06-24 Sels de furosemide. BE904986A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/751,763 US4663348A (en) 1985-07-02 1985-07-02 Furosemide salts and pharmaceutical preparations thereof

Publications (1)

Publication Number Publication Date
BE904986A true BE904986A (fr) 1986-12-24

Family

ID=25023379

Family Applications (1)

Application Number Title Priority Date Filing Date
BE6/48235A BE904986A (fr) 1985-07-02 1986-06-24 Sels de furosemide.

Country Status (14)

Country Link
US (1) US4663348A (enExample)
JP (1) JPS625975A (enExample)
AU (1) AU599034B2 (enExample)
BE (1) BE904986A (enExample)
CH (1) CH670448A5 (enExample)
DE (1) DE3619665A1 (enExample)
DK (1) DK312586A (enExample)
FR (1) FR2584405B1 (enExample)
GB (1) GB2189239B (enExample)
IT (1) IT1191972B (enExample)
LU (1) LU86484A1 (enExample)
NL (1) NL8601519A (enExample)
SE (1) SE8602917L (enExample)
ZA (1) ZA864207B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920145A (en) * 1988-02-29 1990-04-24 Gaf Chemical Corporation Water-soluble complexes of water-insoluble pharmaceutical compounds and preparation thereof
IT1237115B (it) * 1989-10-24 1993-05-18 Sali della furosemide, procedimento per la loro preparazione e composizionni farmaceutiche che li contengono
WO1993010983A1 (en) * 1991-12-03 1993-06-10 Kokuyo Kabushiki Kaisha Filing device openable/closable on both sides
US8722668B2 (en) * 1998-12-23 2014-05-13 Daryl W. Hochman Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders
US8008283B2 (en) * 1998-12-23 2011-08-30 Neurotherapeutics Pharma, Inc. Methods and compositions for the treatment of neuropsychiatric disorders
US7214711B2 (en) * 1998-12-23 2007-05-08 Neurotherapeutics Pharma Llc Method of treating migraine headache without aura
FI114538B (fi) * 2001-01-12 2004-11-15 Finnfeeds Finland Ltd Glysiinibetaiinin käyttö verenpainetta alentavan tuotteen valmistukseen
US6989386B2 (en) * 2002-04-30 2006-01-24 Dana-Farber Cancer Institute Pharmaceutically active ornithine derivatives, ammonium salts thereof and methods of making same
RU2416404C1 (ru) * 2009-10-05 2011-04-20 Государственное образовательное учреждение высшего профессионального образования "Алтайский государственный медицинский университет Федерального агентства по здравоохранению и социальному развитию" Средство, обладающее мочегонным действием
JP5337261B2 (ja) * 2010-02-10 2013-11-06 キッセイ薬品工業株式会社 縮合複素環誘導体の塩及びその結晶
PT2981258T (pt) * 2013-04-05 2020-10-19 Scpharmaceuticals Inc Formulações farmacêuticas para administração subcutânea de furosemida
ES3041602T3 (en) 2018-12-10 2025-11-13 Sq Innovation Ag Pharmaceutical compositions of furosemide and uses thereof
US11246851B2 (en) 2019-01-04 2022-02-15 Sq Innovation Ag Pharmaceutical compositions of furosemide and uses thereof
US12397005B2 (en) 2019-01-04 2025-08-26 Sq Innovation Ag Pharmaceutical compositions of torsemide and uses thereof
PH12021551811A1 (en) 2019-01-31 2022-03-21 Scpharmaceuticals Inc Concentrated liquid pharmaceutical formulations of furosemide and methods of administering the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3058882A (en) * 1959-12-28 1962-10-16 Hoechst Ag N'-substituted-3-carboxy-6-halo-sulfanilamide and derivatives thereof
US3565920A (en) * 1966-12-29 1971-02-23 Ciba Geigy Corp 5-sulfamyl-anthranilic acids
DK138322B (da) * 1970-07-13 1978-08-14 Dumex Ltd As Fremgangsmåde til fremstilling af N-substituered antranilsyrederivater.
FR2210607A1 (en) * 1972-12-20 1974-07-12 Aries Robert 4-Chloro-5-sulphamoyl-N-furfuryl-anthranilic acid prepn. - from furfural and 4-chloro-5-sulphamoyl anthranilic acid
DE2343218C2 (de) * 1973-08-28 1986-08-07 Hoechst Ag, 6230 Frankfurt Furosemid enthaltende Pellets
LU74319A1 (enExample) * 1976-02-09 1977-08-19
DE3025367A1 (de) * 1980-07-04 1982-01-28 Hoechst Ag, 6000 Frankfurt Salz aus furosemid oder piretanid als saeurekomponente und penbutolol oder (-)-3-(4- (3-(3,4-dimethoxyphenylaethylamino)-2-hydroxy-propoxy) -phenyl ) -crotonsaeurenitril als basenkomponente, verfahren zu seiner herstellung, dieses enthaltendes mittel und dessen verwendung

Also Published As

Publication number Publication date
JPS625975A (ja) 1987-01-12
AU599034B2 (en) 1990-07-12
IT8648183A0 (it) 1986-06-25
AU5889086A (en) 1987-01-08
FR2584405B1 (fr) 1989-02-24
IT1191972B (it) 1988-03-31
CH670448A5 (enExample) 1989-06-15
GB8615275D0 (en) 1986-07-30
US4663348A (en) 1987-05-05
GB2189239A (en) 1987-10-21
DE3619665A1 (de) 1987-01-08
DK312586D0 (da) 1986-07-01
ZA864207B (en) 1987-02-25
SE8602917L (sv) 1987-01-03
GB2189239B (en) 1989-02-01
LU86484A1 (fr) 1986-12-02
FR2584405A1 (fr) 1987-01-09
IT8648183A1 (it) 1987-12-25
SE8602917D0 (sv) 1986-07-01
NL8601519A (nl) 1987-02-02
DK312586A (da) 1987-01-03

Similar Documents

Publication Publication Date Title
BE904986A (fr) Sels de furosemide.
BE905928A (fr) Dispositif therapeutique pour administrer un agent actif sur la peau.
KR870002835A (ko) 이온화성 소수성약제의 약제학적 제조방법
ATE53762T1 (de) Fluessige diclofenac-zubereitungen.
DE122007000022I1 (de) Pharmazeutische Zusammensetzungen, welche ausgewählte Lanthancarbonathydrate enthalten
BE899635A (fr) Compositions pharmaceutiques.
BE888082A (fr) Compositions cosmetiques ou pharmaceutiques sous forme d'emulsions stables du type huile-dans-l'eau
DK1098643T3 (da) Phenylacetylglutamin, phenylacetylisoglutamin og/eller phenylacetat til behandling af neoplastiske sygdomme
Hosain et al. Measurement of glomerular filtration rate using chelated ytterbium-169
Knowles et al. Absorption and excretion of 7-chloro-1, 3-dihydro-3-hydroxy-5-phenyl-2H-1, 4-benzodiazepin-2-one (oxazepam) in humans. Determination of the drug by gas-liquid chromatography with electron capture detection
Park Mary McLeod Bethune
Beckett et al. The absorption, blood concentrations and excretion of pentazocine after oral, intramuscular or rectal administration to man
FR2627084B1 (fr) Formes galeniques solides contenant une ou plusieurs substances peroxydiques liberant de l'oxygene actif et utilisees en hygiene bucco-dentaire ou comme decontaminants de lentilles ophtalmiques
ES2036661T3 (es) Un metodo para preparar una preparacion farmaceutica de pie de atleta.
DK0893121T3 (da) Flydende oral medicinopløsning
DE69617868D1 (de) Geschmacksmaskierte wässrige Lösungen enthaltend Ibuprofen und Menthol
Aitken et al. Plasma levels following administration of sodium meclofenamate by various routes
RU2000103880A (ru) Способ моделирования цирроза печени
Mascher et al. Metabolism and effect of nitrates
ES2060057T3 (es) Soluciones acuosas conteniendo proteina.
RU97119262A (ru) Способ улучшения зимовки пчелиных семей
NL179704C (nl) Intraveneus toe te dienen waterige oplossing van een in water oplosbaar farmaceutisch geschikt zout van een sulfonamide en 2,4-diamino-5-(3,4,5-trimethoxybenzyl)-pyrimidine als sulfonamidepotentieerder en de bereiding ervan.
Chart et al. Effect of aminoglutethimide in adrenal regeneration hypertension
USD217273S (en) Block for planter and wall construction
Gil et al. Skin permeation of flurbiprofen through excised rat skin from poloxamer 407 gel

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: WARNER-LAMBERT CY

Effective date: 19920630